Overview
Details
Chat
Moderna, Inc. (MRNA.US) Q3 2021 Earnings Conference Call
Live streaming time: 04/11/2021 12:00
Moderna, Inc. is committed to the development of transformative messenger ribonucleic acid (mRNA) therapeutics. Its product line includes preventive vaccines, cancer vaccines, intratumoral immunooncology, local regenerative therapy, systemic secretion therapy, and systemic intracellular therapy. The company was founded in 2010 by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien, and is headquartered in Cambridge, Massachusetts.
Risk and Disclaimer Statement:
The content on this page reflects the personal opinion of the author and is intended solely as general information for your reference. It shall not be construed as advice or a basis for any specific investment, business, or commercial decisions. The views expressed in the content do not represent any position of LongPort or any investment recommendations or endorsements related to LongPort. LongPort does not make any guarantee or commitment to the truthfulness, accuracy, or originality of the content. Investors should analyze the risks related to the investment based on their own circumstances and seek advice from a professional investment advisor when necessary.